Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-20

Clinical Trial Update: Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease [Phase 2, Phase 3]

View source ↗

Summary

The study update indicates completion of Phase 2 and Phase 3 trials evaluating Frondanol for anti-inflammatory effects in adults with inflammatory bowel disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Frondanol (Frondanol)

Snippet

Sponsor: Mohammed Bin Rashid University of Medicine and Health Sciences | Conditions: Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate | Phase 2, Phase 3 | Status: COMPLETED